Health Industry

Latest KFF Health News Stories

Empresas de capital riesgo invierten en el negocio de los ensayos clínicos de medicamentos. ¿Cuál es el riesgo para los pacientes?

KFF Health News Original

Para lanzar un nuevo fármaco al mercado, la Administración de Alimentos y Medicamentos (FDA) exige a las farmacéuticas estudios exhaustivos para demostrar su seguridad y eficacia. Conseguir que un medicamento salga al mercado unos meses antes, y con menos gastos de lo habitual, puede traducirse en beneficios millonarios para el fabricante.

Trickle of Covid Relief Funds Helps Fill Gaps in Rural Kids’ Mental Health Services

KFF Health News Original

Only a sliver of the funding given to state, local, and tribal governments through the American Rescue Plan Act has been steered to mental health nationwide, but mental health advocates and clinicians hope the money it provides will help address gaps in care for children. In Appalachian Ohio, the funding is helping expand services.

Patient Mistrust and Poor Access Hamper Federal Efforts to Overhaul Family Planning

KFF Health News Original

For decades, many women of color, particularly those with low incomes, had little control over their family planning care. Now, a White House effort aims to give patients more choices as abortion care evaporates, but patients remain wary of providers.

Audits — Hidden Until Now — Reveal Millions in Medicare Advantage Overcharges

KFF Health News Original

Taxpayers had to foot the bills for care that should have cost far less, according to records released after KHN filed a lawsuit under the Freedom of Information Act. The government may seek to recover up to $650 million as a result.

Mistrust and Polarization Steer Rural Governments to Reject Federal Public Health Funding

KFF Health News Original

As the covid-19 pandemic grinds on, Elko County, Nevada, still lacks a public health department. Yet its elected leaders rejected federal funds that could have helped it create one. Decisions like the one in Elko, and ones made by officials with other state and local governments, leave health experts concerned about whether the country’s public health infrastructure will be prepared to handle future health challenges.

As STDs Proliferate, Companies Rush to Market At-Home Test Kits. But Are They Reliable?

KFF Health News Original

The popularity of at-home covid tests has amplified calls from public health researchers and diagnostic companies to make home testing similarly routine for sexually transmitted diseases. But FDA guidelines are lagging.

Los mentores trabajan, sin límites, en la recuperación de adicciones

KFF Health News Original

Los especialistas en apoyo a pares están ellos mismos en recuperación y se los contrata para ayudar a otros. Pueden vincularse con los pacientes de una manera distinta que los profesionales de salud.

The Player-Coaches of Addiction Recovery Work Without Boundaries

KFF Health News Original

States, tribes, and local governments are figuring out how best to spend billions of dollars from an opioid lawsuit settlement. One option they’re considering is funding peer support specialists, who guide people recovering from addiction as they do it themselves.

Sick Profit: Investigating Private Equity’s Stealthy Takeover of Health Care Across Cities and Specialties

KFF Health News Original

Private equity firms have shelled out almost $1 trillion to acquire nearly 8,000 health care businesses, in deals almost always hidden from federal regulators. The result: higher prices, lawsuits, and complaints about care.

Thousands of Experts Hired to Aid Public Health Departments Are Losing Their Jobs

KFF Health News Original

As the covid-19 pandemic raged, an independent nonprofit tied to the Centers for Disease Control and Prevention hired an army of seasoned professionals to fill the gaps in the country’s public health system. Now, the money has largely run out, and state and local health departments are again without their expertise.

Defense Department Health Plan Cuts Its Pharmacy Network by Nearly 15,000 Outlets

KFF Health News Original

Many of the pharmacies were small, independent operations that had decided not to participate next year because of the lowered reimbursement being offered. But they were surprised by an early dismissal, and some patients with specialized drug needs could face difficulties in the transition.